Outsourcing has been called ‘one of the greatest organisational and industry structure shifts of the century’. This shift has been particularly marked within the pharmaceutical sector, with pharmaceutical and biotechnology companies now outsourcing at almost every stage of the value chain.

Over the last decade outsourcing has become an important strategic issue for pharmaceutical companies; rising pressure to reduce costs and time-to-market has led to outsourcing of traditional non-core functions such as manufacturing and clinical trials, and also increasingly of technically demanding areas such as drug discovery and biotech R&D.

The Pharma-Bio Outsourcing Conference and Exhibition is the premier forum for discussion of developments in outsourcing strategies across the pharmaceutical research and development value chain.

This event offers delegates the opportunity to hear from leading experts about emerging global strategies in the rapidly evolving drug discovery and development arena, and to network with the world’s leading manufacturers and suppliers showcasing their latest products and services in the exhibition areas.